Skip to main content

Table 1 IC50 values of compound studied (MTT assay)

From: Antitumor activity of the protein kinase inhibitor 1-(β-D-2′-deoxyribofuranosyl)-4,5,6,7-tetrabromo- 1H-benzimidazole in breast cancer cell lines

 

IC50 [μM]

Cell line

24 h

48 h

MDA-MB-231

61.93 ± 7.15

27.00 ± 4.10

MCF-7

56.04 ± 6.88

23.67 ± 5.70

SK-BR-3

59.46 ± 6.54

8.92 ± 2.08

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us